Bryan, Garnier & Co advises healthcare software vendor Regas on its sale to Bid Equity

Bryan, Garnier & Co advises healthcare software vendor Regas on its sale to Bid Equity

News published on December Thursday 14, 2017
Share on


Regas is a SaaS software vendor, dedicated to health and social care industries, enabling hospitals, social institutions and youth welfare organisations to plan, optimize and document their services.

The company was founded in Woerden in the Netherlands in 1997 and substantially expanded its presence in Benelux and lately in Germany with the takeover of the German software provider Daarwin (2015).

The company has been growing at a double-digit rate for years.

The sale to BID Equity will allow for further expansion of the company.

Transaction highlights

Bryan, Garnier & Co acted as the sole advisor to Regas shareholders and management on the sale of their shares to Hamburg-based private equity company BID Equity.

We ran a structured process with several strategic and PE firms contacted globally and selected four for the due diligence phase.

This marks another landmark transaction for Bryan Garnier’s recent software deals including the sale of Mediane to Turennes Capital, the sale of Impeo to Riverside's portfolio company Fadata and the sale of Prima Solutions to The Carlyle Group.

About Regas

Regas provides cloud-based electronic patient file software with flexible and adaptable workflow solutions for clients in the care sector ranging from social shelters to youth and mental care providers in the Benelux. In Germany, the company provides software in the youth care segment. Since its foundation in 1997 Regas has become the market leader in several market segments in the Netherlands, Belgium and Germany.


About Bid Equity

BID Equity is a new generation Private Equity firm investing in medium-sized software and technology companies in Germany and Austria. They act as a partner for entrepreneurs and management teams, and believe in active ownership and operational value creation to help companies reach the next level of their development. The BID Equity team contributes a unique set of capabilities and expertise well beyond the contribution of traditional financial investors to its portfolio firms.


About Bryan, Garnier & Co

Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Media & Telecoms, Healthcare, Smart Industries & Energy, Consumer, Brands & Retail and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.


Deal team

Falk Müller-Veerse
T: +49 89 242 262 66

Thibaut de Smedt
T: +33 1 56 68 75 75

Lars Dürschlag
T: +49 89 242 262 68

Berk Kirca
Vice President
T: +49 89 242 262 65

Awa Sow
T: +33 1 56 68 75 87

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities